SCHEMBL5249193

SCHEMBL5249193

O=C(NCC(F)(F)F)c1ccc(-n2cc(C(=O)NCCc3cccs3)nn2)c(OCCCCCCF)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.42
▸ RAB9A P51151 8/20 0.42
▸ SMN1; SMN2 Q16637 6/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ MAPT P10636 1/20 0.42
▸ BRD4 O60885 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HPGD P15428 3/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ MIF P14174 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ TAAR1 Q96RJ0 1/20 0.38
▸ DRD2 P14416 2/20 0.36
▸ DRD3 P35462 2/20 0.36
▸ NAMPT P43490 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5244507 0.93 BRD4 (0.40) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL5248133 0.91 NPC1 (0.47) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL5247111 0.91 NPC1 (0.41) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL3115101 0.88 SMPD1 (0.43) DRD2DRD3CNR2
SCHEMBL5247505 0.87 SMPD1 (0.38) BRD4DRD2DRD3CNR2
SCHEMBL5246678 0.87 SMPD1 (0.39) ALDH1A1BRD4HPGDKDM4EDRD2
SCHEMBL5244759 0.86 SMPD1 (0.38) POLBDRD2DRD3
SCHEMBL3115558 0.86 TP53 (0.41) SMN1; SMN2LMNAHPGDCYP1A2CYP2C9
SCHEMBL5245844 0.86 NPC1 (0.40) NPC1RAB9ASMN1; SMN2ALDH1A1BRD4
SCHEMBL5247405 0.86 MLYCD (0.41) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1867331-A1 TRIAZOLE DERIVATIVE AND THE USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2007-12-19 — — EP disclosed
Send feedback